BioSpace News Archive

Verseon Corporation announces that all resolutions put to shareholders were duly passed during the Annual General Meeting (“AGM”) held on November 5, 2018 at 14:00 PDT.

Devin’s Message Foundation has partnered with national youth speaker Brooks Gibbs to create an Autism-informed educational film that is being shown to schools in Western New York and expanding to more than 1,000 schools around the world for free.

INNIO today announces that Advent International has completed the acquisition of GE’s Distributed Power business and is now a stand-alone energy company rebranded as INNIO.

Community Healthcare Network (CHN), a multi-site FQHC is partnering with Brooklyn-based behavioral health start-up, Valera Health, to strengthen their collaborative care management program for patients with comorbid behavioral and chronic health conditions.

Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced results from the large, prospective, multi-center validation CONTACT 2 study that met its primary and secondary endpoints, demonstrating significantly higher diagnostic performance of nCLE with Cellvizio® compared to standard of care methods in patients with pancreatic cyst lesions (PCLs).

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 19 highly anticipated late-breaking clinical trial results on Tuesday morning at VIVA 18, hosted at Wynn Las Vegas.

21st Century Oncology CEO, Kim Commins-Tzoumakas, has announced the launch of an updated corporate logo and a new “BE” brand to support institutional changes taking place within the organization.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, announces Ali McBride, Pharm.D., M.S., BCOP, FAzPA, FASHP, as the keynote speaker for the 2018 Directions in Oncology Pharmacy™ meeting.

CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of joint surface lesions, announced today the publication of a study demonstrating that the Agili-C™ implant promotes the regenerative capacity of articular cartilage defects in human cadaveric ex-vivo model.

Attendees at the New York and New Jersey Pain Medicine Symposium 2018: Evolving Advanced Pain Therapies, hosted by the NY and NJ Societies of Interventional Pain Physicians (NYSIPP & NJSIPP), November 8-11, 2018, Hyatt Regency Jersey City, NJ will be among the first to learn about the benefits of participating in the newly launched Monogram Integrated Health Services (MIHS).